PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Frost & Sullivan Honours Miltenyi Biotec GmbH for Outstanding Product Innovation - Miltenyi Biotec GmbH 2006 Frost & Sullivan European Life Sciences and Pharmaceuticals Product Innovation of the Year Award for its creation of a unique PrepProtect™ Stabilization Buffer
Frost & Sullivan Honours Miltenyi Biotec GmbH for Outstanding Product Innovation

 

NewswireToday - /newswire/ - London, United Kingdom, 2007/02/15 - Miltenyi Biotec GmbH 2006 Frost & Sullivan European Life Sciences and Pharmaceuticals Product Innovation of the Year Award for its creation of a unique PrepProtect™ Stabilization Buffer.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The 2006 Frost & Sullivan Product Innovation of the Year Award in gene expression analysis technologies is presented to Miltenyi Biotec GmbH for its creation of a unique PrepProtect™ Stabilization Buffer. PrepProtect Buffer is non-toxic and stabilises the RNA, DNA or protein in cell or tissue samples for relatively long periods. It thereby prevents RNA degradation before isolation and analysis, and ensures more reliable downstream processing.

The parallel handling of multiple biological samples and quick processing are critical for accurate downstream analysis such as gene expression profiling. While this process requires high-quality RNA, chemical instability and susceptibility to ubiquitous RNases create major challenges. In this context, the PrepProtect Buffer enables much-needed RNA stabilisation.

"PrepProtect allows RNA stabilisation, in both freshly prepared as well as previously frozen samples," notes Frost & Sullivan Research Analyst Sirisha R S. "A fresh cell or tissue sample mixed with PrepProtect Solution can be stabilised for at least one day at 37 degreesC, one week at 18 degreesC to 25 degreesC, one month at 4 degreesC or for archival storage below -20 degreesC."

The PrepProtect Solution prevents the degradation of RNA when direct analysis or quick-freezing, post sample collection, is not possible and when samples are being transported without dry ice or frozen tissue needs to be weighed and dissected. Due to its ability to facilitate sample collection and the parallel processing of multiple samples, as well as to allow samples to be shipped without the use of dry ice, the PrepProtect Solution has emerged as a reliable tool for downstream applications.

"PrepProtect also has the ability to seep through previously frozen material, and protects RNA during thawing," adds Ms. Sirisha. "When the frozen samples are incubated in the PrepProtect solution, RNA in cells are stable for up to one hour at room temperature or overnight at 4 degreesC, thereby helping researchers prepare samples and weigh or dissect tissues before RNA isolation."

PrepProtect Buffer also reduces the hardness of the frozen tissues by softening their structure. It thus facilitates tissue lysis and homogenisation without prior pulverisation with mortar and pestle. Furthermore, it helps to preserve both the quantity and quality of RNA for downstream analysis such as quantitative polymerase chain reaction (PCR) or microarray analysis. Moreover, along with the RNA stabilisation, PrepProtect Buffer preserves the integrity of DNA and denatured proteins in biological samples.

"Miltenyi Biotec has successfully developed a wide product portfolio with its MACS® Technology-based solutions for basic biomedical and clinical research, particularly for cell separation, cell analysis, cell culture, molecular biology, and clinical research applications," states Ms. Sirisha. "At least three or four products are released in the market every month, and this exemplifies the productivity of the company's R&D initiatives and its commitment to product innovation."

The Frost & Sullivan Product Innovation Award is presented each year to the company that has demonstrated excellence in new products and technologies within their industry. The recipient company has shown innovation by launching a broad line of emerging products and technologies.

Frost & Sullivan Best Practices Awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About Frost & Sullivan
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community, by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics.

About Miltenyi Biotec
Miltenyi Biotec, founded in 1989, has become a successful diversified biotechnology company. With subsidiaries and distributors around the world, the company has almost 1000 employees.

The product portfolio comprises more than 800 products for cell separation, cell analysis, cell culture, and molecular biology in basic and biomedical research.

Miltenyi Biotec invented and developed MACS® Technology, the gold standard method in magnetic cell separation. MACS® Technology offers a multitude of applications: from small-scale to large-scale cell purifications, from cell to biomolecule separations, from lab bench to clinical research applications.

With the MACSmolecular product range, Miltenyi Biotec offers innovative reagents, instruments, and services for molecular cell analysis. This includes highly specific molecule purifications and revolutionary in-column enzymatic reactions with convenient MACS® Technology, single-cell analysis, as well as cutting-edge gene expression profiling products and services.

For further information, please contact:
Prof. Dr. Uwe A. O. Heinlein
Head of Corporate and Marketing Communications
Miltenyi Biotec GmbH
Germany
T: +49-2204-8306-6590
uweh[.]miltenyibiotec.de

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Frost & Sullivan Honours Miltenyi Biotec GmbH for Outstanding Product Innovation

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Miltenyi Biotec GmbH | Best Practices
Publisher Contact: Beatrix Beck 
+44-(0)1865-398-698 beatrix.beck[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience
Pyxis™ ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care
BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0
MDxHealth Announces Agreement with Istituto Diagnostico Varelli for Distribution of SelectMDx Throughout Central-South Italy
BD Veritor™ System Meets FDA’s New Performance Requirements for Rapid Influenza Antigen Detection Tests
Sub-Sahara Africa - Increase in Western Lifestyles Leads to Dire Need for Chronic Prescription Drugs Finds Frost & Sullivan
BD Initiates New Industry Alliance to Combat Rising Opioid Crisis
BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-oncology
Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi
BD Announces Early Access Program for BD Resolve™ Single-Cell Analysis Platform
Precision Medicine Unlocks the Future of Targeted Therapy in the Global Healthcare Industry Finds Frost & Sullivan
Sciformix Corporation Receives Prestigious 2017 Global Outsourcing Customer Service Leadership Award from Frost & Sullivan

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)